Sofia Spyridonidou

819 total citations
31 papers, 663 citations indexed

About

Sofia Spyridonidou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sofia Spyridonidou has authored 31 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Sofia Spyridonidou's work include Cancer-related Molecular Pathways (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Sofia Spyridonidou is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Sofia Spyridonidou collaborates with scholars based in Greece, Germany and United States. Sofia Spyridonidou's co-authors include Christos Yapijakis, Antonis Vylliotis, Stavros Vassiliou, Eleftherios Vairaktaris, Efstratios Patsouris, Emeka Nkenke, Spyridoula Derka, Friedrich Wilhelm Neukam, Despina Perrea and Zoe Serefoglou and has published in prestigious journals such as Oral Oncology, American Journal of Hematology and Acta Oncologica.

In The Last Decade

Sofia Spyridonidou

30 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Spyridonidou Greece 15 298 232 211 83 83 31 663
Vera Balz Germany 17 331 1.1× 364 1.6× 145 0.7× 172 2.1× 22 0.3× 38 838
Mingjing He China 16 443 1.5× 194 0.8× 95 0.5× 29 0.3× 78 0.9× 26 723
Chia Wen Tsai Taiwan 18 396 1.3× 228 1.0× 261 1.2× 34 0.4× 15 0.2× 40 700
Wen Shin Chang Taiwan 16 244 0.8× 170 0.7× 213 1.0× 28 0.3× 15 0.2× 35 499
Zhikun Ma China 19 748 2.5× 306 1.3× 302 1.4× 24 0.3× 136 1.6× 38 1.1k
Gabriella Aquino Italy 17 581 1.9× 207 0.9× 436 2.1× 136 1.6× 49 0.6× 44 1000
Patrick T. Hennessey United States 13 474 1.6× 118 0.5× 227 1.1× 129 1.6× 48 0.6× 15 775
Bin Qiao China 18 408 1.4× 353 1.5× 188 0.9× 44 0.5× 21 0.3× 36 874
Yu-Juen Cheng Taiwan 10 711 2.4× 331 1.4× 530 2.5× 137 1.7× 12 0.1× 13 1.2k
Jinyu Kong China 17 407 1.4× 135 0.6× 249 1.2× 12 0.1× 85 1.0× 27 674

Countries citing papers authored by Sofia Spyridonidou

Since Specialization
Citations

This map shows the geographic impact of Sofia Spyridonidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Spyridonidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Spyridonidou more than expected).

Fields of papers citing papers by Sofia Spyridonidou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Spyridonidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Spyridonidou. The network helps show where Sofia Spyridonidou may publish in the future.

Co-authorship network of co-authors of Sofia Spyridonidou

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Spyridonidou. A scholar is included among the top collaborators of Sofia Spyridonidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Spyridonidou. Sofia Spyridonidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yapijakis, Christos, Sofia Spyridonidou, Antonis Vylliotis, et al.. (2013). Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma. Archives of Dermatological Research. 305(4). 333–339. 15 indexed citations
2.
Spyridonidou, Sofia, Christos Yapijakis, Emeka Nkenke, et al.. (2009). A common 9 bp deletion in the ataxia-telangiectasia-mutated gene is not associated with oral cancer.. PubMed. 29(8). 3191–3. 2 indexed citations
3.
Vairaktaris, Eleftherios, Zoe Serefoglou, Dimitrios Avgoustidis, et al.. (2008). Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncology. 45(3). 247–253. 51 indexed citations
4.
Vairaktaris, Eleftherios, Christos Yapijakis, Zoe Serefoglou, et al.. (2008). Gene expression polymorphisms of interleukins-1β, -4, -6, -8, -10, and tumor necrosis factors-α, -β: regression analysis of their effect upon oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 134(8). 821–832. 57 indexed citations
5.
Vairaktaris, Eleftherios, Sofia Spyridonidou, Antonis Vylliotis, et al.. (2008). Diabetes and oral oncogenesis.. PubMed. 27(6B). 4185–93. 27 indexed citations
6.
Vairaktaris, Eleftherios, Veronica Papakosta, Spyridoula Derka, et al.. (2008). H-ras and c-fos exhibit similar expression patterns during most stages of oral oncogenesis.. PubMed. 22(5). 621–8. 6 indexed citations
7.
Vairaktaris, Eleftherios, Stavros Vassiliou, Sofia Spyridonidou, et al.. (2007). Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats. Journal of Cancer Research and Clinical Oncology. 134(3). 337–344. 5 indexed citations
8.
Yapijakis, Christos, E Vairaktaris, Stavros Vassiliou, et al.. (2007). The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. Journal of Cancer Research and Clinical Oncology. 133(10). 787–791. 54 indexed citations
9.
Vairaktaris, Eleftherios, Christos Yapijakis, Christos Tsigris, et al.. (2007). Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncologica. 46(8). 1097–1102. 33 indexed citations
10.
Vairaktaris, Eleftherios, Sofia Spyridonidou, Christos Yapijakis, et al.. (2007). Abundance and localization of skeletal muscle-related erbB2 may stimulate tumour growth during initial stages of oral oncogenesis.. PubMed. 7(2). 185–90. 4 indexed citations
11.
Vairaktaris, Eleftherios, Christos Yapijakis, Emeka Nkenke, et al.. (2007). The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer. American Journal of Hematology. 82(11). 1010–1012. 13 indexed citations
12.
Vairaktaris, Eleftherios, Lampros Goutzanis, Christos Yapijakis, et al.. (2007). Diabetes enhances cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis. International Journal of Oral and Maxillofacial Surgery. 37(1). 60–65. 10 indexed citations
13.
Vairaktaris, Eleftherios, Stavros Vassiliou, Sofia Spyridonidou, et al.. (2007). Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathway. Journal of Cranio-Maxillofacial Surgery. 35(8). 382–387. 1 indexed citations
14.
Vairaktaris, E, Sofia Spyridonidou, Veronica Papakosta, et al.. (2007). The hamster model of sequential oral oncogenesis. Oral Oncology. 44(4). 315–324. 87 indexed citations
15.
Vairaktaris, Eleftherios, Stavros Vassiliou, Emeka Nkenke, et al.. (2007). EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis.. PubMed. 21(5). 791–6. 8 indexed citations
16.
Vairaktaris, Eleftherios, Zoe Serefoglou, Christos Yapijakis, et al.. (2007). Coagulation-related factors, thrombomodulin and protein Z, are not associated with risk for oral cancer.. PubMed. 27(4B). 2449–51. 4 indexed citations
17.
Vairaktaris, Eleftherios, Vasileios Ragos, Christos Yapijakis, et al.. (2007). FGFR-2 and -3 play an important role in initial stages of oral oncogenesis.. PubMed. 26(6B). 4217–21. 20 indexed citations
18.
Vairaktaris, Eleftherios, Georgios Papageorgiou, Spyridoula Derka, et al.. (2006). Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis. Journal of Cancer Research and Clinical Oncology. 133(4). 227–233. 11 indexed citations
19.
Derka, Spyridoula, Eleftherios Vairaktaris, Veronica Papakosta, et al.. (2006). Cell proliferation and apoptosis culminate in early stages of oral oncogenesis. Oral Oncology. 42(5). 540–550. 42 indexed citations
20.
Papakosta, Veronica, Eleftherios Vairaktaris, Antonis Vylliotis, et al.. (2006). The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.. PubMed. 26(4B). 2957–62. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026